The Yash‑Kiara starrer ‘Toxic: A Fairy Tale for Grown‑Ups’ has crossed ₹330 crore worldwide by day 10 and is edging close to the ₹250 crore mark in India. Despite mixed critical reviews, the film continues to draw massive audience interest.
- ‘Toxic’ surpasses ₹330 crore globally on Day 10
- Indian box‑office inches toward the ₹250 crore target
- Strong audience pull despite critical skepticism
The Bollywood power‑pair Yash and Kiara Advani have propelled Toxic: A Fairy Tale for Grown‑Ups to a worldwide gross of over ₹330 crore within ten days, with domestic earnings nearing the coveted ₹250 crore milestone. This represents a 34 percent jump from the previous day, underscoring robust word‑of‑mouth and aggressive digital marketing.
Historical Background
Yash previously cemented his box‑office clout with hits like ‘K.G.F.’ and ‘Rocky Handsome’, while Kiara gained mass appeal through films such as ‘Shershaah’ and ‘Bhool Bhulaiyaa 2’. ‘Toxic’ was marketed as an adult‑oriented fantasy drama, a departure that initially sparked critical doubt but ultimately attracted a youthful demographic eager for fresh narratives.
Why This Matters
BozokMedia analysis shows that crossing the ₹250 crore threshold in India not only signals massive revenue but also amplifies ancillary streams—streaming rights, overseas distribution, and brand endorsements for the leads.
“‘Toxic’s box‑office momentum highlights the power of audience‑driven hype over traditional critical endorsement.”
Financial analysts predict that such a high‑grossing venture will encourage investors to fund more high‑budget, genre‑bending projects, reflecting a shift in Indian audience preferences toward complex, morally ambiguous storytelling.
Frequently Asked Questions
Q1: Will ‘Toxic’ replicate its Indian success in overseas markets?
A: Early performance in Europe and the Middle East is positive, suggesting further growth in international territories.
Q2: Could critical backlash affect the film’s box‑office trajectory?
A: Experts believe sustained social‑media buzz will likely keep the earnings curve upward despite mixed reviews.